An observational study in Pulmonary Arterial Hypertension (PAH), sponsored by Xijing Hospital. Not yet recruiting. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-24.
Sponsored by Xijing Hospital · Observational
This is a multicenter retrospective cohort study on pulmonary arterial hypertension. It is expected to collect data from no less than 5,000 patients to compare the long-term overall survival of patients with and without diabetes, and analysis the risk factors of the overall survival .
761 studies on the registry are indexed under Pulmonary Arterial Hypertension; 142 are open to participants now.
This study's planned enrollment of 5,000 is above the median of 100 across 197 observational studies indexed under Pulmonary Arterial Hypertension.
Browse Pulmonary Arterial Hypertension studies →Xijing Hospital is the lead sponsor of 465 studies on the registry; 157 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with pulmonary hypertension
Exclusion Criteria:
patients with pulmonary arterial hypertension and diabetes
Other: Standard medical treatment
pulmonary arterial hypertension without comorbid diabetes
Other: Standard medical treatment
Standard medical treatment
Overall Survival
Time from diagnosis of pulmonary hypertension to death
Time frame: 10 years
Pulmonary Artery Pressure(PAP)
Time frame: baseline
Brain natriuretic peptide
Time frame: baseline
blood glucose
Time frame: baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Arterial Hypertension→
Xijing Hospital